Hilltelligence markHilltelligence
Bills/H.R. 4101119th Congress

Cancer Drug Parity Act of 2025

House: Referred
Companion bill: S. 5004(Related bill)
Cosponsors
31
Introduced
2025-06-24
Last action
2025-06-24

Referred to the House Committee on Education and Workforce.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Referred to the House Committee on Education and Workforce.

  2. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

Policy area

Health

Sign in to view Hilltelligence’s potential-cosponsor analysis.